Home

abs520007 (25 Citations)

Mouse IFN-γ ELISA Kit

Datasheet
Collect
Share：

Request bulk quotation

Add to Cart

Product Details
FAQ
Citations(25)
Pictures
Documents

Tips : This product is for research use only. Not for use in diagnostic prodcedures.

Dear customer, if you have any questions or want to know about our products, you can click the "I want to ask" button to fill in your questions. Unsuccessful submission? Please contact worldwide@absin.cn.

Ask questions

Adenosine A2A receptor-mediated interactions between Th1+ T cells and the choroid plexus epithelium via IFN-γ signalling control T-Cell infiltration in experimental autoimmune encephalomyelitis

Chenxing Qi, Yuwen Yang, Ping Tang, Cheng Zheng, Xuhang Li, Nan Jiang, Jia Qu, Jiang-Fan Chen, Wu Zheng

Cell Commun Signal. 2025 Feb 17 .

Influencing factors：8.200

Engineered oncolytic virus coated with anti-PD-1 and alendronate for ameliorating intratumoral T cell hypofunction

Yufu Zhu, Xuefeng Zhang, Jiaqi Jin, Xiaoqian Wang, Yang Liu, Jian Gao, Diancheng Hang, Lin Fang, Hengzhu Zhang, Hongmei Liu

Exp Hematol Oncol. 2025 Feb 15 .

Influencing factors：9.400

Exosomal miR-184 facilitates bladder cancer progression by targeting AKR1C3 and inducing immune escape via IRF2-CXCL10 axis

Wenwei Ying, Ying Zhao, Yuhui He, Yisen Deng, Xiaoming Gan, Peizhe Li, Xing Chen, Zhenshan Ding

Biochim Biophys Acta Mol Basis Dis. 2024 Dec 15 .

Influencing factors：6.200

Developing an erythrocyte‒MHC-I conjugate for cancer treatment

Yuehua Liu, Xiaoqian Nie, Xingyun Yao, Huafeng Shou, Yang Yuan, Yun Ge, Xiangmin Tong, Hsiang-Ying Lee, Xiaofei Gao

Cell Discovery. 2024 Oct 1 .

Influencing factors：13.000

AI-powered omics-based drug pair discovery for pyroptosis therapy targeting triplenegative breast cancer

Boshu Ouyang , Caihua Shan , Shun Shen , Xinnan Dai, Qingwang Chen , Xiaomin Su , Yongbin Cao , Xifeng Qin , Ying He , Siyu Wang , Ruizhe Xu, Ruining Hu, Leming Shi, Tun Lu, Wuli Yang , Shaojun Peng , Jun Zhang , Jianxin Wang , Dongsheng Li , Zhiqing Pang

Nature Communications. 2024 Aug 30 .

Influencing factors：14.700

Flt3 ligand augments immune responses to soluble PD1-based DNA vaccine via expansion of type 1 conventional DCs

Zongyu Cai,Yaru Qiao,Qimuge Wuri,Ke Zhang,Xueli Qu,Shiqi Zhang,Hui Wu,Jiaxin Wu,Chu Wang,Xianghui Yu,Wei Kong,Haihong Zhang

International Immunopharmacology. 2024 Aug 20 .

Influencing factors：4.800

Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial

Yue-Yun Chen, Pei-Pei Wang, Yang Hu, Yong Yuan, Yu-Shang Yang, Hua-Shan Shi, Qing Hao, Zhen Lin, Jiang-Fang Tian, Yue Zheng, Ting Liu, Pan-Pan Lin, Heng Xu, Xue-Lei Ma, Li Yang, Zhen-Yu Ding

British Journal of Cancer. 2024 Aug 20 .

Influencing factors：6.400

USP24 promotes hepatocellular carcinoma tumorigenesis through deubiquitinating and stabilizing TRAF2

Nana Zhou,Chaoqin Guo,Xiangyu Li,Linglan Tu,Jingyang Du,Qiyi Qian,Juejiashan Li,Dongsheng Huang,Qiuran Xu,Xiaoliang Zheng0

BIOCHEMICAL PHARMACOLOGY. 2024 Aug 8 .

Influencing factors：5.300

The XCL1-Mediated DNA Vaccine Targeting Type 1 Conventional Dendritic Cells Combined with Gemcitabine and Anti-PD1 Antibody Induces Potent Antitumor Immunity in a Mouse Lung Cancer Model

Ke Zhang, Qimuge Wuri, Zongyu Cai, Xueli Qu, Shiqi Zhang, Hui Wu, Jiaxin Wu, Chu Wang, Xianghui Yu, Wei Kong, Haihong Zhang

International journal of molecular sciences. 2024 Feb 4 ; 3:-

Influencing factors：5.600

FGF19/FGFR4 signaling contributes to hepatocellular carcinoma survival and immune escape by regulating IGF2BP1-mediated expression of PD-L1

Chaoqin Guo, Nana Zhou, Yisong Lu, Mingshan Mu, Zilin Li, Xu Zhang, Linglan Tu, Jingyang Du, Xiangyu Li, Dongsheng Huang, Qiuran Xu, Xiaoliang Zheng

BIOMEDICINE & PHARMACOTHERAPY. 2023 Dec 3 .

Influencing factors：7.500

Self-Cross-Linked Chitosan/Albumin-Bound Nanoparticle Hydrogel for Inhibition of Postsurgery Malignant Glioma Recurrence

Wei Long, Shangfei Li, Yuhan Yang, An Chen, Menghan Xu, Hao Zhai, Ting Cai, Yayun Peng

ACS Applied Materials & Interfaces. 2023 Dec 1 .

Influencing factors：9.500

Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response

Rong Tang, Jin Xu, Wei Wang, Qingcai Meng, Chenghao Shao, Yiyin Zhang, Yubin Lei, Zifeng Zhang, Yuan Liu, Qiong Du, Xiangjie Sun, Di Wu, Chen Liang, Jie Hua, Bo Zhang, Xianjun Yu, Si Shi, Chinese Study Group for Pancreatic Cancer

Cell reports Medicine. 2023 Oct 17 ; 10:-

Influencing factors：14.300

肿瘤微环境中肝癌免疫逃逸相关生物标志物的荧光成像研究

武传琛

山东师范大学. 2023 Sep 1 .

LPS adsorption and inflammation alleviation by polymyxin B-modified liposomes for atherosclerosis treatment

Huiwen Liu, Honglan Wang, Qiyu Li, Yiwei Wang, Ying He, Xuejing Li, Chunyan Sun, Onder Ergonul, Füsun Can, Zhiqing Pang, Bo Zhang, Yu Hu

Acta Pharmaceutica Sinica B. 2023 Jun 13 .

Influencing factors：14.5

基于Notch/STAT信号通路研究神香草对哮喘免疫失衡的调节作用

潘雅朦;康雨彤;蔡晓翠;张思蓉;贺金华

中南药学. 2023 May 17 .